In the present study, we found that the SNRPD2 and SNRPD3 acted as the oncogenes in the MM patients, and high expressions of the SNRPD2 and SNRPD3 were associated with the metastasis and worse prognosis. This evidence concerns the gene SNRPD2 and Miyoshi myopathy.